Nitroaspirin

CAS : 175033-36-0

Ref. TM-T16328

Informations sur le produit

• Nom: Nitroaspirin
• Synonymes: NCX 4016, 2-(Acetyloxy)-3-[(Nitrooxy)Methyl]Phenyl Ester, Benzoic Acid, 2-Acetoxybenzoic acid 3-nitrooxymethylphenyl ester, 2-AcetyloxybenzoicAcid3-NitrooxymethylphenylEster, 3-((Nitrooxy)methyl)phenyl 2-acetoxybenzoate, 3-(Nitroxymethyl)phenyl 2-acetoxybenzoate, 3-[(Nitrooxy)Methyl]Phenyl 2-(Acetyloxy)Benzoate, Benzoic acid, 2-(acetyloxy)-, 3-[(nitrooxy)methyl]phenyl ester, Ncx 4016
• CAS: 175033-36-0

Description

Nitroaspirin (NCX 4016) is a nitric oxide donor and a nitro-derivative of Aspirin, which combines with Nitroaspirin to inhibit cyclooxygenase. Nitroaspirin induces significant induction of cell cycle arrest and apoptosis in Cisplatin-resistant human ovarian cancer cells via down-regulation of EGFR/PI3K/STAT3 signaling and modulation of Bcl-2 family proteins. Nitroaspirin has antithrombotic and antiplatelet properties and acts as a direct and irreversible inhibitor of COX-1.

• Marque: Targetmol

Propriétés chimiques

• Masse moléculaire: 331.28
• Formule: C₁₆H₁₃NO₇
• Degré de pureté: 98.45%
• Couleur/Forme: Solid